Prospective multicenter study of the epidemiology, molecular identification, and antifungal susceptibility of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis isolated from patients with candidemia

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 12, 2011, Pages 5590-5596

  Cantón, Emilia ^a   Pemán, Javier ^a   Quindós, Guillermo ^b   Eraso, Elena ^b   Miranda Zapico, Ilargi ^b   Álvarez, María ^c   Merino, Paloma ^d   Campos Herrero, Isolina ^e   Marco, Francesc ^f   De La Pedrosa, Elia Gomez G ^g   Yagüe, Genoveva ^h   Guna, Remedios ⁱ   Rubio, Carmen ^j   Miranda, Consuelo ^k   Pazos, Carmen ^l   Velasco, David ^m   Alcoba, Julia ⁿ   Ayats, Josefina ^o   Borrell, Nuria ^p   Bratos, Miguel Ángel ^q   Buendía, Buenaventura ^r   Camarena, Juan J ^s   Echeverría, Julia ^t   Esperalba, Juliana ^u   Ezpeleta, Guillermo ^v   Fernández Natal, Isabel ^w   Fontanals, Dionisia ^x   García, Julio ^y   García García, Inmaculada ^z   García Tapia, Ana María ^aa   Gómez Nieto, Amelia ^ab   Gomila, Bárbara ^ac   Guinea, Jesús ^ad   Iglesias, Isabel ^ae   Linares Sicilia, María José ^af   Martín Mazuelos, Estrella ^ag   Martínez Alarcón, José ^ah   Navarro, David ^ai   Del Molino, Luisa Pérez ^aj   Porras, Aurelio ^ak   Ramírez, Inmaculada ^al   Rezusta, Antonio ^am   Roselló, Eva María ^an   Royo, Gloria ^ao   De Pipaon, María Teresa Ruiz Pérez ^ap   Sánchez Reus, Ferrán ^aq   Suárez, Anabel ^ar   Torroba, Luis ^as   more..

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^e Servicio de Microbiología   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL RAMÓN Y CAJAL   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

ⁱ HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^j HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^l Servicio de Microbiología Clínica Hospital S Pedro de Alcántara   (Spain)

^m Hospital Lucus Augusti   (Spain)

ⁿ HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^o HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^p HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^q HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^r HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^s HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^t HOSPITAL DONOSTIA   (Spain)

^u HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^v HOSPITAL DE BASURTO   (Spain)

^w Department of Internal Medicine   (Mexico)

^x Departamento d Enfermedades Infecciosas   (Spain)

^y HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^z HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^aa HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^ab HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^ac HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^ad HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^ae Xerencia de Xestion Integrada de Vigo SERGAS   (Spain)

^af HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^ag HOSPITAL UNIVERSITARIO DE VALME   (Spain)

^ah Hospital General   (Spain)

^ai HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^aj HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^ak HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^al HOSPITAL VIRGEN DE LA CONCHA   (Spain)

^am HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^an HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^ao Hospital General Universitario   (Spain)

^ap HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^aq HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^ar HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^as Instituto de Investigación Sanitaria de Navarra   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; CANDIDA; CANDIDA METAPSILOSIS; CANDIDA ORTHOPSILOSIS; CANDIDA PARAPSILOSIS; CANDIDEMIA; CHILD; COLORIMETRY; CONTROLLED STUDY; FEMALE; FUNGUS ISOLATION; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HEMATOLOGY; HUMAN; INTENSIVE CARE UNIT; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DIAGNOSIS; MULTICENTER STUDY (TOPIC); NEWBORN; PEDIATRICS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; CANDIDEMIA; CANDIDIASIS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, FUNGAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; SPAIN; SPECIES SPECIFICITY; YOUNG ADULT;

EID: 81555206767     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00466-11     Document Type: Article

References (57)

1. Alexander, B. D., et al. 2007. Comparative evaluation of Etest and Sensititre YeastOne panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J. Clin. Microbiol. 45:698-706. (Pubitemid 46427680)
2. Almirante, B., et al. 2006. Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J. Clin. Microbiol. 44:1681-1685. (Pubitemid 43726255)
3. Arendrup, M. C., et al. 2011. National surveillance of fungemia in Denmark (2004 to 2009). J. Clin. Microbiol. 49:325-334.
4. Benjamin, D. K., Jr., et al. 2006. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 117:84-92.
5. Blyth, C. C., et al. 2009. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics 123:1360-1368.
6. Bonassoli, L. A., M. Bertoli, and T. I. Svidzinski. 2005. High frequency of Candida parapsilosis on the hands of healthy hosts. J. Hosp. Infect. 59:159-162. (Pubitemid 40058043)
7. Branchini, M. L., M. A. Pfaller, J. Rhine-Chalberg, T. Frempong, and H. D. Isenberg. 1994. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J. Clin. Microbiol. 32:452-456. (Pubitemid 24033911)
8. Cantón, E., A. Espinel-Ingroff, J. Pemán, and L. del Castillo. 2010. In vitro fungicidal activity of echinocandins against Candida metapsilosis, C. orthopsilosis and C. parapsilosis by time killing studies. Antimicrob. Agents Chemother. 54:2194-2197.
9. Cantón, E., et al. 2005. Sensititre YeastOne caspofungin susceptibility testing of Candida clinical isolates: correlation with results of NCCLS M27-A2 multicenter study. Antimicrob. Agents Chemother. 49:1604-1607. (Pubitemid 40463401)
10. Cassone, A., et al. 1995. Biotype diversity of Candida parapsilosis and its relationship to the clinical source and experimental pathogenicity. J. Infect. Dis. 171:967-975.
11. Chen, Y. C., et al. 2010. Molecular epidemiology and antifungal susceptibility of Candida parapsilosis sensu stricto, Candida orthopsilosis, and Candida metapsilosis in Taiwan. Diagn. Microbiol. Infect. Dis. 68:284-292.
12. Clerihew, L., T. L. Lamagni, P. Brocklehurst, and W. McGuire. 2006. Invasive fungal infection in very low birth weight infants: national prospective surveillance study. Arch. Dis. Child. Fetal Neonatal ed. 91:F188-F192.
13. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, approved standard. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Clinical and Laboratory Standards Institute. 2011. Minutes of the Subcommittee on Antifungal Susceptibility Testing meeting. Clinical and Laboratory Standards Institute, Wayne, PA.
15. Colombo, A. L., et al. 2006. Epidemiology of candidemia in Brazil: a nationwide sentinel surveillance of candidemia in eleven medical centers. J. Clin. Microbiol. 44:2816-2823. (Pubitemid 44228575)
16. Costa-de-Oliveira, S., C. Pina-Vaz, D. Mendonca, and R. A. Goncalves. 2008. A first Portuguese epidemiological survey of fungaemia in a university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 27:365-374.
17. de Toro, M., M. J. Torres, R. Maite, and J. Aznar. 2011. Characterization of Candida parapsilosis complex isolates. Clin. Microbiol. Infect. 17:418-424.
18. Diekema, D. J., et al. 2009. In vitro activity of seven systemically active antifungal agents against a large global collection of rare Candida species as determined by CLSI broth microdilution methods. J. Clin. Microbiol. 47: 3170-3177.
19. Gacser, A., W. Schafer, J. S. Nosanchuk, S. Salomon, and J. D. Nosanchuk. 2007. Virulence of Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis in reconstituted human tissue models. Fungal Genet. Biol. 44:1336-1341. (Pubitemid 350046346)
20. García-Effron, G., et al. 2011. Assessment of two new molecular methods for identification of Candida parapsilosis sensu lato species. J. Clin. Microbiol. 49:3257-3261.
21. Godoy, P., et al. 2003. Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals. Mem. Inst. Oswaldo Cruz 98:401-405. (Pubitemid 38030559)
22. Gómez, J., et al. 2009. Nosocomial candidemia at a general hospital: the change of epidemiological and clinical characteristics. A comparative study of 2 cohorts (1993-1998 versus 2002-2005). Rev. Iberoam. Micol. 26:184-188.
23. Gómez-López, A., et al. 2008. Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain. Antimicrob. Agents Chemother. 52:1506-1509. (Pubitemid 351522020)
24. Goncalves, S. S., et al. 2010. Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil. Clin. Microbiol. Infect. 16:885-887.
25. Kato, M., M. Ozeki, A. Kikuchi, and T. Kanbe. 2001. Phylogenetic relationship and mode of evolution of yeast DNA topoisomerase II gene in the pathogenic Candida species. Gene 272:275-281. (Pubitemid 32695420)
26. Kocsube, S., et al. 2007. Occurrence and genetic variability of Candida parapsilosis sensu lato in Hungary. J. Med. Microbiol. 56:190-195.
27. Krcmery, V., and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260. (Pubitemid 37554852)
28. Lehmann, P. F., D. Lin, and B. A. Lasker. 1992. Genotypic identification and characterization of species and strains within the genus Candida by using random amplified polymorphic DNA. J. Clin. Microbiol. 30:3249-3254.
29. Levy, I., L. G. Rubin, S. Vasishtha, V. Tucci, and S. K. Sood. 1998. Emergence of Candida parapsilosis as the predominant species causing candidemia in children. Clin. Infect. Dis. 26:1086-1088. (Pubitemid 28215469)
30. Lin, D., L. C. Wu, M. G. Rinaldi, and P. F. Lehmann. 1995. Three distinct genotypes within Candida parapsilosis from clinical sources. J. Clin. Microbiol. 33:1815-1821.
31. Lockhart, S. R., S. A. Messer, M. A. Pfaller, and D. J. Diekema. 2008. Geographic distribution and antifungal susceptibility of the newly described species Candida orthopsilosis and Candida metapsilosis in comparison to the closely related species Candida parapsilosis. J. Clin. Microbiol. 46:2659-2664.
32. Miranda-Zapico, I., et al. 2011. Prevalence and antifungal susceptibility patterns of new crypto-species inside the species-complexes Candida parapsilosis and Candida glabrata among blood isolates from a Spanish tertiary hospital. J. Antimicrob. Chemother. 66:2315-2322.
33. Neu, N., et al. 2009. Epidemiology of candidemia at a children's hospital, 2002 to 2006. Pediatr. Infect. Dis. J. 28:806-809.
34. Orsi, C. F., B. Colombari, and E. Blasi. 2010. Candida metapsilosis as the least virulent member of the 'C. parapsilosis' complex. Med. Mycol. 48:1024-1033.
35. Pemán, J., et al. 2011. Variación de la epidemiologia de las fungemias y de la sensibilidad a fluconazol de los aislamientos en los últimos 10 años en España: resultados del estudio FUNGEMYCA. Rev. Iberoam. Micol. 28:91-99.
36. Pemán, J., E. Canton, and M. Gobernado. 2005. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 24:23-30. (Pubitemid 40179128)
37. Pfaller, M. A., et al. 2011. Wild-type MIC distributions and epidemiological cutoff values for posaconazole and voriconazole and Candida spp. as determined by 24-hour CLSI broth microdilution. J. Clin. Microbiol. 49:630-637.
38. Pfaller, M. A., et al. 2010. Wild-type MIC distributions and epidemiological cutoff values for the echinocandins and Candida spp. J. Clin. Microbiol. 48:52-56.
39. Pfaller, M. A., et al. 2008. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal panel for antifungal susceptibility testing of the echinocandins anidulafungin, caspofungin, and micafungin. J. Clin. Microbiol. 46:2155-2159.
40. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
41. Pfaller, M. A., and D. J. Diekema. 2010. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 36:1-53.
42. Pfaller, M. A., et al. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular, clinical, and microbiological data to arrive at specie-specific interpretative criteria. Drug Resist. Updat. 14:164-176.
43. Pryce, T. M., et al. 2006. Rapid identification of fungal pathogens in BacT/ ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions. Diagn. Microbiol. Infect. Dis. 54:289-297.
44. Roy, B., and S. A. Meyer. 1998. Confirmation of the distinct genotype groups within the form species Candida parapsilosis. J. Clin. Microbiol. 36:216-218. (Pubitemid 28047462)
45. Sarvikivi, E., et al. 2005. Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. J. Clin. Microbiol. 43:2729-2735. (Pubitemid 40827946)
46. Silva, A. P., I. M. Miranda, C. Lisboa, C. Pina-Vaz, and A. G. Rodrigues. 2009. Prevalence, distribution, and antifungal susceptibility profiles of Candida parapsilosis, C. orthopsilosis, and C. metapsilosis in a tertiary care hospital. J. Clin. Microbiol. 47:2392-2397.
47. Szabo, Z., et al. 2009. In vitro efficacy of 5 antifungal agents against Candida parapsilosis, Candida orthopsilosis, and Candida metapsilosis as determined by time-kill methodology. Diagn. Microbiol. Infect. Dis. 64:283-288.
48. Tavanti, A., A. D. Davidson, N. A. Gow, M. C. Maiden, and F. C. Odds. 2005. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J. Clin. Microbiol. 43:284-292. (Pubitemid 40096313)
49. Tavanti, A., L. A. Hensgens, E. Ghelardi, M. Campa, and S. Senesi. 2007. Genotyping of Candida orthopsilosis clinical isolates by amplification fragment length polymorphism reveals genetic diversity among independent isolates and strain maintenance within patients. J. Clin. Microbiol. 45:1455-1462.
50. Tay, S. T., S. L. Na, and J. Chong. 2009. Molecular differentiation and antifungal susceptibilities of Candida parapsilosis isolated from patients with bloodstream infections. J. Med. Microbiol. 58:185-191.
51. van Asbeck, E. C., K. V. Clemons, M. Martinez, A. J. Tong, and D. A. Stevens. 2008. Significant differences in drug susceptibility among species in the Candida parapsilosis group. Diagn. Microbiol. Infect. Dis. 62:106-109.
52. Varga, I., et al. 2008. Comparison of killing activity of caspofungin against Candida parapsilosis, Candida orthopsilosis and Candida metapsilosis. J. Antimicrob. Chemother. 62:1466-1468.
53. Viudes, A., et al. 2002. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis. 21:767-774. (Pubitemid 35435697)
54. Weems, J. J., Jr. 1992. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin. Infect. Dis. 14:756-766.
55. White, P. L., et al. 2006. A consensus on fungal polymerase chain reaction diagnosis?: a United Kingdom-Ireland evaluation of polymerase chain reaction methods for detection of systemic fungal infections. J. Mol. Diagn. 8:376-384.
56. White, P. L., A. Shetty, and R. A. Barnes. 2003. Detection of seven Candida species using the Light-Cycler system. J. Med. Microbiol. 52:229-238.
57. Zaoutis, T. E., et al. 2005. Antifungal susceptibility of Candida spp. isolated from pediatric patients: a survey of 4 children's hospitals. Diagn. Microbiol. Infect. Dis. 52:295-298. (Pubitemid 41297566)